British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017.

Autor: Smith CH; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, U.K., Jabbar-Lopez ZK; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, U.K., Yiu ZZ; The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9NT, U.K., Bale T; British Dermatology Nursing Group representative, Aneurin Bevan Health Board, Wales, U.K., Burden AD; Department of Dermatology, Royal Infirmary of Edinburgh, Edinburgh, EH3 9HA, U.K., Coates LC; British Society for Rheumatology, Chapel Allerton Hospital, Leeds, LS7 4SA, U.K.; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, U.K., Cruickshank M; National Guideline Centre, Royal College of Physicians, London, NW1 4LE, U.K., Hadoke T; Patient representatives., MacMahon E; Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, U.K., Murphy R; Department of Dermatology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S10 2JF, U.K., Nelson-Piercy C; Women's Health Academic Centre, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, U.K., Owen CM; Department of Dermatology, East Lancashire Hospitals NHS Trust, Burnley, BB10 2PQ, U.K., Parslew R; Department of Dermatology, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, L7 8XP, U.K., Peleva E; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, SE1 9RT, U.K., Pottinger E; National Guideline Centre, Royal College of Physicians, London, NW1 4LE, U.K., Samarasekera EJ; National Guideline Centre, Royal College of Physicians, London, NW1 4LE, U.K., Stoddart J; Independent chair, Healthcare Quality Improvement Partnership, London, EC2Y 9AE, U.K., Strudwicke C; Patient representatives., Venning VA; Department of Dermatology, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7LE, U.K., Warren RB; The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9NT, U.K., Exton LS; British Association of Dermatologists, London, W1T 5HQ, U.K., Mohd Mustapa MF; British Association of Dermatologists, London, W1T 5HQ, U.K.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2017 Sep; Vol. 177 (3), pp. 628-636.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Bullous pemphigoid: identification and treatment.

Autor: Nazarko, Linda

Publikováno v: Journal of General Practice Nursing (GPN); Dec2024, Vol. 10 Issue 4, p54-59, 6p

Environmental triggers of pemphigus vulgaris and bullous pemphigoid: a case control study.

Autor: Stone, Corey, Bak, Grace, Oh, Daniel, Zhao, Cathy, Venugopal, Supriya, Kumar, Kuldeep, Murrell, Dedee F.

Publikováno v: Frontiers in Medicine; 2024, p1-9, 9p

The approach of dermatologists in the UK to the treatment of bullous pemphigoid: results of a national survey.

Autor: Taghipour K, Mohd Mustapa MF, Highet AS, Venning VA, Kirtschig G

Publikováno v: Clinical and experimental dermatology [Clin Exp Dermatol] 2013 Apr; Vol. 38 (3), pp. 311-3.